Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 35,861 shares at $44.39 ($1.6M) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Seasonal sale ($1.6M) by President and CEO — this insider has traded DNLI in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.39 | 8,516 | $378K | 23.5% |
| 2 | $44.39 | 8,516 | $378K | 23.5% |
| 3 | $45.30 | 9,012 | $408K | 25.4% |
| 4 | $45.30 | 9,012 | $408K | 25.4% |
| 5 | $46.35 | 805 | $37K | 2.3% |
| Total | $44.89 avg | 35,861 |
| $1.6M |
| 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |